SomnoMed Ltd SOMNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.18
- Day Range
- $0.16–0.19
- 52-Week Range
- $0.13–0.62
- Bid/Ask
- $0.20 / $0.30
- Market Cap
- $41.80 Mil
- Volume/Avg
- 6,000 / 28,673
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.37
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 22
- Website
- https://www.somnomed.com/au
Comparables
Valuation
|
Metric
|
SOMNF
|
688617
|
SWAV
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 40.35 | 78.21 |
Price/Book Value | 1.33 | 14.99 | 16.70 |
Price/Sales | 0.37 | 17.66 | 16.28 |
Price/Cash Flow | — | 45.11 | 52.56 |
Price/Earnings
SOMNF
688617
SWAV
Financial Strength
|
Metric
|
SOMNF
|
688617
|
SWAV
|
|---|---|---|---|
Quick Ratio | 1.44 | 2.63 | 12.49 |
Current Ratio | 1.73 | 3.43 | 13.81 |
Interest Coverage | — | 212.52 | 19.59 |
Quick Ratio
SOMNF
688617
SWAV
Profitability
|
Metric
|
SOMNF
|
688617
|
SWAV
|
|---|---|---|---|
Return on Assets (Normalized) | — | 22.96% | 18.92% |
Return on Equity (Normalized) | — | 30.66% | 36.87% |
Return on Invested Capital (Normalized) | — | 28.46% | 20.45% |
Return on Assets
SOMNF
688617
SWAV
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Tkhzwdxx | Njljfn | $183.1 Bil | |||
| Stryker Corp
SYK
| Mnjvvxdfp | Kqcv | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Sqzwhpx | Hzjpf | $110.1 Bil | |||
| Medtronic PLC
MDT
| Fypqlmpy | Vnfns | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Nynnxytvm | Mzxlwwy | $37.6 Bil | |||
| DexCom Inc
DXCM
| Kgfghpmp | Kqs | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Ylcddmnj | Svnggh | $24.1 Bil | |||
| Steris PLC
STE
| Kyyblymj | Zyvkl | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Qxlhzllcl | Gzz | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Rjjfhjkct | Xqdrtzs | $16.6 Bil |